1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
AbbVie Enters Underwriting Agreement for $1.5 Billion in Notes
Financial Results, Press Release
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
To Acquire Apogee Therapeutics, Deepening Immunology Portfolio, Investor Presentation
AbbVie Stockholders Elect Class II Directors and Ratify Auditor Appointment
Reports First-Quarter 2026 Financial Results
Annual Report to Security Holders
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Additional Proxy Soliciting Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Annual Report of Employee Stock Purchase
Free Writing Prospectus
Specialized Disclosure Report